The Supreme Court of the US has said it will consider a lower court ruling that would restrict access to the abortion pill mifepristone and is considered to be tied to the
In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with David Solomon, CEO of Mithra Pharmaceuticals, about the current women’s health landscape and wha
New data for Astellas Pharma’s non-hormonal menopause therapy fezolinetant has shown it remains effective to 24 weeks, consolidating the evidence of the drug as it starts
Bayer has launched updated packaging for one of its over-the-counter (OTC) products in the UK with a QR code designed to assist people who are blind or partially sighted.
A digital therapeutic (DTx) designed to help women cope with mood disturbances after giving birth has been shown to be effective in a randomised clinical trial, according
Researchers in the US have developed a prototype of a wearable device that can monitor oestrogen in sweat and could play a role in women’s health and fertility.